Updates in Diagnostic and Adjunctive Diagnostic Techniques for Thyroid Diseases

A team from Shandong Provincial Hospital integrated data from the U.S. National Health and Nutrition Examination Survey and Chinese multicenter health examination data to explore factors influencing the reference intervals of TSH and thyroid hormones. The results showed that with advancing age, TSH increased and total triiodothyronine (T3) decreased, while total thyroxine (T4) remained relatively […]

New Findings in Thyroid Disease Testing and Inappropriate Ultrasound Screening

Grade 2 subclinical hypothyroidism (G2SCH), defined as a serum thyroid-stimulating hormone (TSH) level exceeding 10 mU/L, often requires treatment. A team from the Second Affiliated Hospital of Zhejiang University School of Medicine used machine learning algorithms on routine physical examination indicators and identified four factors most strongly associated with G2SCH: age, hemoglobin, red blood cell […]

Obesity Criteria and Assessment Items

Professor Li Xia from the Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University, points out that the iCARDIO Alliance Global Implementation Guidelines for Obesity Management 2025 defines overweight as a BMI of 23–27.5 kg/m² and obesity as a BMI ≥ 27.5 kg/m² for Chinese (Asian) populations. These thresholds are lower […]

Diagnosis of Postmenopausal Sarcopenic Obesity

At the 27th Annual Conference of the Chinese Society of Diabetes (CDS 2025), Professor Shen Jie from the Eighth Affiliated Hospital of Southern Medical University systematically elaborated on diagnostic approaches for postmenopausal sarcopenic obesity in this specific population.The European Working Group on Sarcopenia in Older People (EWGSOP2) clearly states that low muscle strength is the […]

CKD remission is most achievable when the disease is detected at an early stage

Given the profound implications of CKD remission for reducing the risk of premature death and kidney failure, we advocate establishing CKD remission as a clear and achievable clinical goal.CKD remission is most likely to be achieved when the disease is detected early — before substantial eGFR loss or severe albuminuria develops. Population-based screening combining eGFR […]

Professor Chen Yanming: Multi-Omics-Based Prediction and AI-Powered Precision Diagnosis of DR

At the 27th Annual Conference of the Chinese Society of Diabetes (CDS 2025), Professor Chen Yanming from the Third Affiliated Hospital of Sun Yat-Sen University delivered a presentation on multi-omics-based prediction and AI-powered precision diagnosis of diabetic retinopathy (DR).Multi-Omics-Based Prediction and AI-Powered Precision Diagnosis of DRThe application of multi-omics technologies — including genomics, epigenomics, transcriptomics, […]

Many People with Diabetes Do Not Meet Their LDL-Cholesterol Targets

“People with diabetes represent a huge at-risk population for coronary heart disease and stroke, yet their cholesterol control is currently the weakest link.”Cholesterol management in diabetic patients has not received the attention it deserves. Epidemiological data show that many people with diabetes do not reach their LDL-cholesterol targets.Patients with diabetes often have multiple metabolic disorders, […]

Professor Chantal Mathieu: Early Intervention in the Integrated Cardiorenal Kidney Metabolic Management of Diabetes

As the number of people living with diabetes continues to rise globally, the management of diabetes‑related complications has become a central topic in clinical research.The International Diabetes Federation World Diabetes Congress (IDF 2025), under the theme “Shape the future of diabetes”, brought together global experts to discuss new advances, technologies and strategies in diabetes care, […]

Two-step strategy predicts advanced liver fibrosis and long-term outcomes in patients with diabetes-fatty liver comorbidity

On January 21, Gut, an authoritative international journal of gastroenterology, online published a study entitled Two-step strategy for predicting advanced liver fibrosis and long-term outcomes in individuals with type 2 diabetes and metabolic dysfunction-associated fatty liver disease. This study provides an effective new approach for risk stratification in patients with type 2 diabetes mellitus (T2DM) […]